Position in BMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,984,423
+$251,113 QoQ
Shares Held
69,150
+12.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#610
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kendall Capital Management holds $22,925,368 across 11 Drug Manufacturers - General names. BMY ranks #2 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,818 | $6,245,201 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
69,150 | $3,984,423 | |
| 3 | GSK |
GSK plc
|
50,941 | $2,670,327 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,682 | $2,529,137 | |
| 5 | JNJ |
Johnson & Johnson
|
8,136 | $2,066,299 | |
| 6 | PFE |
Pfizer Inc
|
49,545 | $1,193,043 | |
| 7 | AMGN |
Amgen Inc
|
2,995 | $1,084,549 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,362 | $1,056,455 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,984,423 | 69,150 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,733,310 | 61,555 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,062,982 | 56,785 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,682,638 | 59,482 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,580,760 | 55,752 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,899,586 | 47,542 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,694,065 | 47,632 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,310,035 | 44,647 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,949,501 | 46,942 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,629,287 | 48,484 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,398,280 | 46,741 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $2,677,443 | 46,131 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,884,720 | 45,109 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $3,107,444 | 44,834 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,149,107 | 43,768 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,237,367 | 45,539 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $3,411,023 | 44,299 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,266,558 | 44,729 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,644,512 | 42,414 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $2,304,198 | 38,942 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $2,208,200 | 33,047 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $1,910,755 | 30,267 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,608,561 | 25,932 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,423,567 | 23,612 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $1,333,701 | 22,682 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $942,006 | 16,900 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||